Results 11 to 20 of about 1,615,665 (249)

Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension

open access: yesPulmonary Circulation, 2019
Pulmonary arterial hypertension is a severe disease for which diagnosis often is delayed. Matrix metalloproteinases have been suggested to play a role in vascular remodeling and pulmonary hypertension development. Our aim was therefore to investigate the
Mattias Arvidsson   +3 more
doaj   +2 more sources

Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America

open access: yesPulmonary Circulation, 2022
Treatment for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in Latin America differs between countries, with regard to disease etiology, health insurance coverage, and drug availability.
Mauricio Orozco‐Levi   +11 more
doaj   +2 more sources

Application of [18F]FLT‐PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers [PDF]

open access: yesPulmonary Circulation, 2021
Pulmonary arterial hypertension is a heterogeneous group of diseases characterized by vascular cell proliferation leading to pulmonary vascular remodelling and ultimately right heart failure. Previous data indicated that 3′‐deoxy‐3′‐[18F]‐fluorothymidine
Liza Botros   +11 more
doaj   +2 more sources

Pulmonary Arterial Hypertension [PDF]

open access: yesThe American Journal of the Medical Sciences, 2008
It is important for the general internist to maintain a high degree of suspicion for pulmonary hypertension in appropriate cases. This article reviews the definition and classification of pulmonary hypertension, epidemiology and risk factors, signs and symptoms, diagnostic approach, and treatment strategies.
Chin, Kelly M., Rubin, Lewis J.
core   +5 more sources

Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension

open access: yesBMC Pulmonary Medicine, 2017
Background Chronic inflammation emerges as a feature of the pathogenesis of pulmonary arterial hypertension (PAH) in experimental models. Alterations of circulating cell subsets have been observed in patients with PAH.
Lars Harbaum   +9 more
doaj   +1 more source

Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood [PDF]

open access: yes, 2005
BACKGROUND: Pulmonary arterial hypertension (PAH) is a potentially fatal vasculopathy that can develop at any age. Adult-onset disease has previously been associated with mutations in BMPR2 and ALK-1.
Haworth, SG   +22 more
core   +1 more source

Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies

open access: yesPulmonary Circulation, 2020
Pulmonary arterial compliance is a measure of the pulsatile afterload of the right ventricle. Lower pulmonary arterial compliance is associated with reduced right ventricular function and worse prognosis in pulmonary hypertension. The effect of pulmonary
Thenappan Thenappan   +9 more
doaj   +1 more source

Pulmonary arterial hypertension [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2013
Abstract Pulmonary arterial hypertension (PAH) is a chronic and progressive disease leading to right heart failure and ultimately death if untreated. The first classification of PH was proposed in 1973. In 2008, the fourth World Symposium on PH held in Dana Point (California, USA) revised previous classifications.
Montani, David   +12 more
openaire   +3 more sources

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension [PDF]

open access: yes, 2011
Background: Endothelin-1 signalling plays an important role in pathogenesis of pulmonary hypertension. Although different endothelin-A receptor antagonists are developed, a novel therapeutic option to cure the disease is still needed.
Norbert Weissmann   +41 more
core   +2 more sources

Effect of Pomegranate Extract (Punica Granatum L) on Pulmonary Arterial Pressure in Sprague Dawley Rat with Pulmonary Arterial Hypertension [PDF]

open access: yes, 2020
Congenital heart disease causes pulmonary arterial hypertension, heart failure, and early death. Pulmonary arterial hypertension causes pulmonary arterial wall remodeling, inflammation, deposition of extracellular matrix protein, collagen synthesis, and ...
Taufiq Hidayat, -   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy